Bioadaptives, Inc.
BDPT- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001575142
No open-market purchases or sales by Bioadaptives, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding BDPT, Q2 2026
No superinvestor reported holding BDPT at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Bioadaptives, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 5, 2025 (view filing) | Apr 9 | 26 daysLate | Frissora Mark PDirector | PPurchase | +4.49M | $0.0752 | +$299.8K | –1 after | Derivative2 lots |
| Dec 3, 2024 (view filing)8:30 PM ET | Nov 22 | 11 daysLate | Dissanayake Gimhana SasankaDirector | PPurchaseCommon | +125.0K | $0.085 | +$10.6K | New position125.0K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Bioadaptives, Inc. at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding BDPT in 13F filings for Q2 2026.